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Abstract
Background: High incidence rates of gastrointestinal tract cancers have been reported in the
Caspian region of Iran. This study aimed to: 1) describe the geographical spatial patterns of
gastrointestinal tract cancer incidence based on cancer registry data and, 2) determine whether
geographical clusters of statistical significance exist.
Methods: The Babol Cancer Registry, which covers the two major northern Iranian provinces of
Mazandaran and Golestan (total population = 4,484,622) was used to identify new gastrointestinal
tract cancer cases during 2001 to 2005. Age-specific cancer incidence rates were calculated for 7
gastrointestinal tract cancer sites in 26 wards of the Mazandaran and Golestan provinces. Spatial
autocorrelation indices, hierarchical Bayesian Poisson models, and spatial scan statistics were used
in measuring the geographic pattern and clusters.
Results: There were non-random spatial patterns in esophageal and stomach cancers that were
similar for both sexes. Clusters of high incidence were identified in esophageal, stomach, colorectal
and liver cancer for both sexes, as well as a possible cluster of pancreas cancer in males.
Conclusion: Gastrointestinal tract cancers exhibit significant spatial clustering of risk in northern
Iran. Further work is needed to relate these geographical patterns to information on potential life-
style and environmental factors.
Background
Approximately 50,000 new cases of cancer occur each year
in the Iranian population of 70.4 million. The most com-
mon organ system involved with more than 38% of all
cancers is the gastrointestinal (GI) tract. Stomach, esopha-
gus, and colorectal are the three most common cancers in
males; in females, after breast cancer, esophagus, stom-
ach, and colorectal are the major cancers [1,2]. Cancer is
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the third most common cause of death in Iran, accounting
for 14% of mortality. Overall, GI cancers account for
nearly half (44.4%) of all cancer related deaths in Iran.
Unfortunately, GI cancers often come to medical atten-
tion when they are at advanced stages and so limited or no
effective therapies are available to treat them [3,4]. Theo-
retically, these cancers may be treatable in their early
stage; therefore early detection is desirable.
A cancer registry maintained by the International Agency
for Research on Cancer (IARC) and the Institute of Public
Health Research of Tehran University showed that from
June 1968 to June 1971 the age-adjusted incidence rates
of esophageal cancer for both males and females from the
north-eastern part of the Golestan province were more
than 100 per 100 thousand persons per year and were
among the highest rates in the world [5-9]. There was evi-
dence of sharp gradients in incidence rates over relatively
short geographical distances. Rates appeared to decrease
moving westward for some 400 km along the southern
Caspian region where the incidence was approximately
one tenth to one fifth that of the Golestan province [5].
Due to the sociopolitical changes in 1979, study of these
cancer rates discontinued before complete patterns of
incidence and the full complement of risk factors could be
established. Until recent years, there was no comprehen-
sive report of incidence rates of cancer in Iran in general
and in the Caspian Sea region in particular. Recently
results of a population-based cancer survey from Ardabil
and Golestan provinces, respectively in the western and
eastern parts of the Caspian region, were published and
showed significant changes in cancer incidence rates in
this region compared to 30 years ago [10,11]. There was
evidence of a declining rate in esophageal cancer [11] but
an increasing rate of colorectal cancer especially in young
(< 40 years) people [12].
To combat this disease, accurate up-to-date epidemiolog-
ical information is an important weapon. The study of
spatial variation in incidence is a vital component of
descriptive epidemiology. Many cancer atlases have been
used for this purpose, and some studies have used formal
statistical analyses of the spatial pattern of the disease
[13,14].
The aim of this study was to examine the geographic pat-
tern of gastrointestinal tract cancer incidence in the south-
ern region of the Caspian Sea using data from a new
cancer registry and active surveillance conducted by the
Institute of Public Health Research of Tehran University of
Medical Sciences in the Mazandaran and Golestan prov-
inces of Iran.
The total population of these two provinces is approxi-
mately 4.5 million (1.6 million in Golestan province)
constituting about 6.4% of the total Iranian population.
As with the population of Iran more generally, the popu-
lation of these two provinces is young: 36% are ≤ 15 years
and less than 4% are > 65 years, and 51% of the popula-
tion live in rural areas. The life expectancy at birth in Maz-
andaran province is 67.7 years for males and 70.5 for
females, and is similar in Golestan [15].
Mazandaran province has an area of about 23,800 km2,
about 1.5% of the land area of Iran and is located in the
north of Iran. Golestan province is located in north east of
Iran (east of Mazandaran), south-east of the Caspian Sea,
and covers an area of 20,900 km2, constituting 1.3% of
the country. Currently, there are 15 and 11 wards in Maz-
andaran and Golestan provinces respectively as shown in
Figure 1.
Methods
Cancer reporting and Babol cancer registry
The Caspian Cancer Registry located in the city of Babol
was established in 1969 by joint collaboration of the Insti-
tute of Public Health Research of Tehran University and
IARC [16]. Activity of this center was discontinued due to
the sociopolitical events of the 1980s in Iran but resumed
in 1995 as a local cancer registry, controlled by Tehran
University of Medical Sciences.
The major sources of data collection related to cancer in
the Babol cancer registry were reports from pathology lab-
oratories, hospitals, and radiology clinics. All 80 diagnos-
tic and treatment centers in the Mazandaran and Golestan
provinces cooperated with the Babol cancer registry. The
registry consisted of a full time physician, an epidemiolo-
gist, a pathologist and a biostatistician. The survey team
responsible for collecting reports of new cancer cases went
to diagnostic and treatment centers and checked records
for cancer cases monthly. Relevant documents were then
sent to the registry office in Babol. Patient name, sex, age
at the time of diagnosis, place of residence, pathologic
diagnosis, and diagnostic methods were collected. Coding
of cancer diagnosis samples was based on the interna-
tional classification of disease for oncology (ICD-O) cod-
ing [17] and were done under direct supervision of
pathology specialists. The Ethics Committee of Tehran
University of Medical Sciences approved these survey
methods and the function of the registry.
Study Population
Residents of Mazandaran and Golestan provinces consti-
tute the study population. The estimated mid year popu-
lation between 2001 until 2005, stratified for sex, age in
five-year intervals, and place of residence (county/city)
was obtained from the statistical center of Iran [18,19].
The cases of interest were all digestive system cancer
patients registered between 2001 until 2005 among theBMC Cancer 2008, 8:137 http://www.biomedcentral.com/1471-2407/8/137
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study population based on ICD-O coding, including
C00–C26. Among these esophageal cancer (C15), stom-
ach cancer (C16), small intestine (C17), colon and rectos-
igmoid cancer (C18, C19), liver (C22), gallbladder (C23),
and pancreas (C25) are investigated here.
Quality of Data Collection
The survey team had access to treatment records of cancer
patients and pathology reports indicating a cancer. Most
private radiology centers recorded the identifying data of
patients and only occasionally kept the radiologic or
sonographic reports, while the public centers, usually
located in the hospitals, kept radiology reports for the
majority of patients. All private and public hospitals and
clinics had a filing system for endoscopy reports. All infor-
mation collected from cooperating centers was checked
again at the Babol cancer registry for completeness, for
accuracy of demographic information, and was cross-
checked with pathological records. Diagnosis of cancer
was based on histopathology in 68.2%, clinical or radiol-
ogy in 29.7% and death certificate only (DCO) in 2.1% of
all cancer cases [20]. The DCO information has not been
used in our analysis. Percentages of microscopic verifica-
tion (MV) for some important GI cancer sites are shown
in Table 1.
About 3% of cases lacked residential information at
county/city level but this ranged from about 1% for can-
cers with high hospitalization and case-fatality rates (e.g.
pancreas) to about 15% for cancers commonly registered
only by pathology reports (e.g. melanoma) [20]. In order
to use the cases with unknown residential information,
the geographic referral pattern for each hospital or diag-
nosis center was used to assign residences on a propor-
tional as-likely basis.
Reported cancer cases were stored in an Excel data bank.
Two independent groups of operators were responsible
for entering new cases in separate data banks and these
were checked against each other to remove data entry
errors. After completion of data entry, all patients were
alphabetically ordered and duplicate cases with the same
name, sex, age and place of residence were eliminated by
manual and computerized searching. A number of resi-
dents of Mazandaran and Golestan seek medical care out-
side the region, mainly in Tehran, and occasionally in
Geographic boundaries of wards in Mazandaran and Golestan provinces in the Caspian Sea region of Iran Figure 1
Geographic boundaries of wards in Mazandaran and Golestan provinces in the Caspian Sea region of Iran.
Table 1: Percentage of microscopic verification for the most 
common gastrointestinal tract cancer sites
Site %
Esophageal 47.7
Stomach 49.6
Colorectal 95.9
Liver 86.4
Bladder 94.7BMC Cancer 2008, 8:137 http://www.biomedcentral.com/1471-2407/8/137
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neighboring Gilan province. In order to make sure of rea-
sonable coverage, cancer cases recorded by Ramsar Cancer
registry (a population based cancer registry conducted by
Tehran Medical University for Gilan province) and Cancer
Institute of Shariati Hospital (a hospital based cancer reg-
istry which is the most reliable and comprehensive cancer
data bank in Tehran) were searched to find any cancer
cases from Golestan and Mazandaran inhabitants for the
same time period (2001–2005).
Concordance of residential place information within one
year of diagnosis was examined for patients with multiple
records during 1998–2000. For this, the coded place of
residence (normally from the earliest source record after
diagnosis), was compared with those of up to five later
source records. Concordance was generally high, for
example, agreement on place of residence between the
first diagnosis record and the next was 94% for stomach
and 92% for esophageal cancer [20].
Statistical methods
We calculated the age standardized incidence ratio (SIR)
of each ward for each sex. The population of the region
was fairly stable between 2001 and 2005 so 2003 figures
were used as the standard population, and indirect stand-
ardization was used to calculate SIR [21]. In order to com-
pare the incidence rates in the Mazandaran and Golestan
region with other parts of the world, directly standardized
incidence rates using the 1970 (Segi's World population)
[22,23] and 2000 (WHO World Population) [24] stand-
ard world population were also calculated.
Two methods were used to measure spatial aggregation of
the ward SIRs; Moran's I and Geary's C [25,26]. Both
measures are a correlation-type index based on continu-
ous data values, but neither index's scale has an interpre-
tation that corresponds to conventional correlation
coefficients which take values in the range (-1, 1). For
Geary's ratio, a value of 1 indicates a random pattern of
spatial variability in incidence, whereas a value greater
than 1 suggests a dispersed pattern with adjacent wards
having different incidence, and a value less than 1 suggests
a clustered pattern in which adjacent wards have similar
incidence. The numeric scale of Moran's I is related to its
expected value, E(I), under a random spatial pattern. Val-
ues less than E(I) are typically associated with a uniform/
dispersed pattern and values greater than E(I) typically
indicate a clustered pattern. The criterion of contiguity
used for calculating the spatial weights matrix was cen-
troid distance [27].
The SIR are crude estimates of underlying ward-specific
relative risks because of sampling uncertainty where they
are based on small numbers of cases hence smoothed esti-
mates of these relative risks (RR) were calculated using the
autoregressive conditional model [28,29]. We used a spa-
tial Poisson model with two random effect terms for each
of the following: a) effects which vary in a structured man-
ner in space (region contiguity); and, b) effects which vary
among municipalities in an unstructured manner (region
heterogeneity). The model takes the following form
Oi ∝ Poisson(Eiλi)
log(λi) = α + hi + bi
where: λi is the relative risk in area i; Oi is the number of
deaths in area i; Ei are the expected number of cases calcu-
lated from indirect standardization; α is the intercept; hi is
the municipal heterogeneity term; and bi is the spatial
term. We used a non-informative Normal prior distribu-
tion for bi and a conditional autoregressive (CAR) prior
distribution for hi[28]. The criterion of contiguity used
was ward adjacency.
The models were fitted using Markov Chain Monte Carlo
(MCMC) simulation methods with improper priors [30].
The Bayesian statistical software (WINBUGS 1.4) was
used for computing two independent Markov Chains
[31]. Initial values of all stochastic nodes of the model
were chosen to provide dispersed initial values without
being excessively over-dispersed. For the common inter-
cept, α, and random effects hi, and bi zero (0) was used to
initiate one chain, and estimated parameter values from a
Poisson model fitted to all GI cancers for both sexes were
used to initiate the other chain. After a burn-in of 50,000
iterations, the following 450,000–650,000 iterations were
sampled from each of the two chains choosing every tenth
iteration to avoid possible autocorrelation. This large
sample approximation of the stationary posterior distri-
bution for each ward relative risk was summarized in
WINBUGS and was subsequently transferred into Geo-
graphic Information System software for mapping.
We used the spatial scan statistic [32] to detect local clus-
ters in smoothed RR maps. This test has been shown to
have good power for detecting localized hot-spots of
excess events [33,34]. The statistic is defined by imposing
circular windows with variable radii ranging from zero to
a user defined upper bound on the map. The base of the
window is in turn centered on each of several possible
centroids. We used SatScan software [35] for this purpose
in which, for each circle, the log likelihood ratio was cal-
culated and the p-values obtained by a Monte Carlo sim-
ulation procedure.
In the present study, for each location and size of the
scanned space in the area under study, the alternative
hypothesis refers to elevated smoothed RR inside the
space as compared to outside, and a p-value less than 0.05BMC Cancer 2008, 8:137 http://www.biomedcentral.com/1471-2407/8/137
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was used for statistical significance. The scan was set at a
maximum spatial cluster size of 25% of the population
under study.
Cartographic display
In this study the RR break points were determined by con-
sidering values in the range 0.1 to 10. This corresponds to
the range -1 to +1 upon logarithmic transformation. Then
this logarithmic scale was divided into 11 equal intervals
centered on zero, the break point values were transformed
back to the original RR scale, and the five middle intervals
were used in the maps. As shown in Figure 2, the middle
category was further divided above and below 1. A red-
green color scheme was used for the maps, with shading
of red for areas with the highest RR, followed by orange
and yellow for areas with moderately elevated RR, light
and medium green for areas with moderately low RR, and
dark green representing areas with the lowest RR. These
maps were redrawn and augmented by highlighting the
most likely clusters with dots and secondary clusters with
slashes.
Results
A total of 5826 new GI cancer cases were diagnosed in
2001–2005 in Mazandaran and Golestan. Of these, 27
cases were diagnosed with rare GI sites (anus and anal
canal (C21), and other unspecified parts of the biliary
tract (C24), or other ill- defined digestive organ (C26))
and were excluded from our spatial analysis. Of 5799
remaining cases, 3504 (60.4%) were male. Table 2 shows
incidence rates, number of cases and autocorrelation indi-
ces for GI cancers by site of the cancer and sex. As
expected, the smoothed ward-specific RR had less varia-
tion than the SIR, e.g. 5th to 95th percentiles for RR were
0.48 to 1.68 and for SIR were 0 to 2.14.
Figure 3 shows strong spatial aggregations in esophageal
cancer for both males and females with a tendency for
high rates in eastern and central wards and low rates in the
west. The significance of these overall spatial trends were
supported by Moran's I and Geary's C indices (Table 2).
Two local clusters were detected in each sex, details of
their location and characteristics are provided in Table 3
and displayed in the left-hand panels of Figure 3. The clus-
ters were very similar for males and females.
Strong spatial clustering was found in both sexes for stom-
ach cancer. According to Figure 4, high rates of stomach
cancer occurred in central, eastern and western wards. The
significant local clusters that were detected are described
in Table 3; the clusters were very similar for males and
females.
The spatial autocorrelation tests in Table 2 did not show
evidence of any global spatial pattern for colorectal can-
cer; this evidence was supported by observed and
smoothed maps of SIR. However there was evidence of
local clusters on northern and central regions as shown in
Figure 5 and described in Table 3.
The findings for liver (Figure 6) and pancreatic cancer
(Tables 2 and 3) were suggestive of weak or no evidence
of spatial correlation although this could be related to the
smaller number of cases for these cancers.
Discussion
Ongoing media reports from non-scientific and scientific
commentators on the apparent disease clusters in north-
ern Iran and their possible causes have raised considerable
alarm in the region with consequent demands for imme-
diate action.
Quality of registry data
The overall quality of the registry data was excellent with
almost all cancers diagnosed by histopathology or clini-
cal/radiology means. There was a small amount of miss-
ing data on place of residence. We consider our use of
imputation for cases with unknown residential informa-
tion to be reasonable because of the small amount of
missing data; any bias that may result will be small and in
the conservative direction towards accepting the null
hypothesis.
Methodology
Application of Moran's I and Geary's C to public health
regional count data merits some thought. Both indices
assess the spatial similarity of deviations of each regional
Relative risk (RR) categories Figure 2
Relative risk (RR) categories.BMC Cancer 2008, 8:137 http://www.biomedcentral.com/1471-2407/8/137
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count with the overall mean regional count. Due to spatial
heterogeneity of regional at-risk population sizes inherent
in regional public health data, observed spatial similarity
in regional deviations from the mean regional count may
simply be due to variations in the regional at risk popula-
tion size [36]. We adjusted these indices for regional
counts by comparing the observed count in each region
with its expectation under the constant risk hypothesis,
rather than comparing the count to the overall mean
count [27,37].
In the MCMC estimation, convergence of relative risk for
the two independent chains was confirmed by plotting
their traces and observing random mixing of all chains
which revealed white noise variation around a common
value with no trend. This was supported by observing
Brooks-Gelman-Rubin diagnostics that clearly satisfied
convergence criteria [38]. As compared with other statisti-
cal methods for spatial epidemiology, the spatial scan sta-
tistic has the following features that make it particularly
suitable as a screening tool for evaluating reported disease
clusters: 1) It adjusts for the inhomogeneous population
density, 2) By searching for clusters without specifying
their size or location, the method ameliorates the prob-
lem of pre-selection bias, 3) The likelihood ratio-based
test statistic takes multiple testing into account and deliv-
ers a single p-value for the test of the null hypothesis, 4) If
the null hypothesis is rejected we can specify the approxi-
mate location of the cluster that caused the rejection. In
addition to the most likely cluster, the method identifies
secondary clusters in the data set and can order them
according to their likelihood ratio [32].
Spatial Analysis
Esophageal Cancer
Among the investigated GI cancer sites, esophageal cancer
is of special interest in this region. Several studies con-
ducted in the 1970's in the Caspian region showed that
areas inhabited by Turkmen had a much higher incidence
rate of esophageal cancer than those areas with a mainly
Persian population, although the differences were less
marked within Golestan province [5,9]. Recent studies
indicate a declining incidence of esophageal cancer in this
region, compared to those reports from 30 years ago. In
fact, age adjusted incidence rates of 165.5 per 100 thou-
sand in males and 195.3 per 100 thousand in the 1970's
had reduced to 43.4 and 36.3 per 100 thousand respec-
tively for males and females, according to a recent study
[11]. Despite this dramatic decrease, the Turkmen plain is
still a high risk area. The increasing pattern of SIR from
west to east was more systematic in females than in males
and there was a secondary cluster in central wards in both
sexes. There was a strong significant correlation (0.85)
between male and female rates, which supports the
notion of a systematic pattern. Tobacco, diet low in fresh
fruit and vegetables, and low socioeconomic status (SES)
Table 2: Incidence rate and directly standardized incidence rates (per 100000 person-years) using the 1970 and 2000 world population 
of GI cancers 2001–2005 in Mazandaran and Golestan provinces of Iran and indices of spatial autocorrelation by cancer site and sex
Cancer Site/Type Sex No. of 
Cases
Incidence 
Rate
1970 world 
population
2000 world 
population
Moran's I# Moran's I 
p-value
Geary's C Geary's C 
p-value
Type of spatial 
pattern
Esophagus M 891 8.10 12.16 14.61 0.016 0.07 0.78 0.04 clustered
F 810 7.23 11.27 12.73 0.021 0.06 0.77 0.04 clustered
Stomach M 1838 15.62 23.04 26.78 0.130 0.04 0.86 0.06 clustered
F 827 6.46 9.92 11.25 0.059 0.06 0.88 0.06 clustered
Colorectal M 556 4.88 6.74 7.55 -0.182 0.08 1.17 0.08 dispersed
F 478 4.32 6.25 6.86 -0.146 0.07 1.14 0.09 dispersed
Gallbladder M 30 0.27 0.21 0.39 -0.033 0.36 0.90 0.24 inconclusive or 
random
F 62 0.56 0.51 0.89 -0.036 0.28 1.01 0.32 inconclusive or 
random
Pancreas M 43 0.39 0.35 0.55 -0.014 0.41 0.89 0.25 inconclusive or 
random
F 24 0.22 0.21 0.34 0.014 0.33 0.93 0.31 inconclusive or 
random
Liver M 103 0.94 0.93 1.49 -0.050 0.11 1.21 0.07 inconclusive or 
random
F 63 0.57 0.58 0.97 -0.053 0.12 1.11 0.90 inconclusive or 
random
Small intestine M 43 0.31 0.44 0.48 -0.004 0.23 1.06 0.34 inconclusive or 
random
F 31 0.23 0.34 0.36 -0.025 0.25 0.93 0.35 inconclusive or 
random
# E(I) for all tests are -0.04BMC Cancer 2008, 8:137 http://www.biomedcentral.com/1471-2407/8/137
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are among major known risk factors for esophageal cancer
[39,40]. A case control study in Turkmen regions of
Northeastern Iran has suggested that tobacco, alcohol,
nass (a drug produced from plant leaves and tobacco),
and perhaps opium (two risk factors of potential impor-
tance in the area) are not the major etiological factors for
esophageal cancer in this region [41]. Esophageal cancer
seems to be homogenously distributed among both Turk-
men and non-Turkmen, and among both city and village
dwellers of Turkmen plain (Gonbad, Minoodasht, and
Kalaleh wards in Figure 1), although a familial study in
Golestan confirmed a strong familial component to
esophageal cancer in the Turkmen population [42]. The
dietary patterns in eastern and western wards appear very
different and these differences can be explained at least in
part by climate and socio-economic differences, however
there are no regional data on food consumption patterns
in the area to explore this in detail.
Stomach Cancer
Stomach cancer shows strong spatial clustering in both
males and females, with a significant correlation (0.84)
Table 3: Spatial scan statistics for detecting local clusters in smoothed RR's
Cancer site Cluster type* p-value No. Cases No. Expected Mean inside** Mean outside** Location
Esophageal; Both Sexes M 0.001 459 257.0 1.74 0.82 Azadshahr, Gonbad, Kolaleh, 
Minoodasht
S 0.001 147 107.3 1.51 0.94 Savadkouh
Esophageal; Male M 0.001 227 137.9 1.59 0.81 Azadshahr, Gonbad, Kolaleh, 
Minoodasht
S 0.001 24 13.7 1.41 0.91 Savadkouh
Esophageal; Female M 0.001 232 119.1 1.83 0.84 Azadshahr, Gonbad, Kolaleh, 
Minoodasht
S 0.001 123 93.6 1.29 0.97 Babol, Savadkouh
Stomach; Both Sexes M 0.001 1262 1038.6 1.51 0.80 Amol, Babol, Ghaemshahr, 
Jouybar, Sari, Savadkouh
S 0.001 333 235.9 1.34 0.93 Gonbad, Minoodasht
S 0.001 167 136.2 1.20 0.94 Ramsar, Tonekabon
Stomach; Male M 0.001 951 769.2 1.42 0.79 Amol, Babol, Ghaemshahr, 
Jouybar, Sari, Savadkouh
S 0.001 206 168.8 1.17 0.92 Gonbad, Minoodasht
S 0.001 114 97.2 1.14 0.92 Ramsar, Tonekabon
Stomach; Female M 0.001 311 269.4 1.64 0.85 Amol, Babol, Ghaemshahr, 
Jouybar, Sari, Savadkouh
S 0.001 101 44.5 2.14 0.99 Gonbad
S 0.001 53 39.0 1.28 1.02 Ramsar, Tonekabon
Colorectal; Both Sexes M 0.001 80 56.1 1.46 0.85 Ramsar, Tonekabon
S 0.001 449 350.6 1.18 0.81 Babol, Babolsar, Ghaemshahr, 
Jouybar, Mahmoudabad, Sari
S 0.001 147 83.8 1.67 0.87 Gorgan
Colorectal; Male M 0.001 289 219.9 1.26 0.78 Amol, Babol, Babolsar, Behshahr, 
Ghaemshahr, Jouybar
S 0.001 81 44.8 1.65 0.86 Gorgan
S 0.001 13 8.1 1.38 0.87 Ramsar
Colorectal; Female M 0.001 45 26.2 1.61 0.85 Ramsar, Tonekabon
S 0.001 66 39.1 1.53 0.88 Gorgan
S 0.001 213 173.8 1.16 0.85 Amol, Babol, Ghaemshahr, Sari, 
Savadkouh
Liver; Both Sexes M 0.001 12 5.2 1.91 0.84 Gorgan
S 0.001 16 10.9 1.33 0.84 Ghaemshahr, Sari
S 0.001 3 0.9 1.17 0.87 Ramsar
Liver; Male M 0.001 20 8.7 1.68 0.86 Gorgan
S 0.001 30 18.1 1.28 0.86 Ghaemshahr, Sari
Liver; Female M 0.001 3 0.9 2.00 1.03 Ramsar
S 0.001 12 5.2 1.78 1.04 Gorgan
S 0.001 12 7.7 1.14 1.06 Sari, Savadkouh
Pancreas; Both Sexes M 0.001 12 7.8 1.95 0.91 Jouybar, Sari
Pancreas; Male M 0.001 15 5.0 1.21 1.01 Jouybar, Sari
* M = most likely cluster; S = Secondary cluster.
** Mean of smoothed RR in wards inside and outside the circles generated by Sat Scan analysis.BMC Cancer 2008, 8:137 http://www.biomedcentral.com/1471-2407/8/137
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between sexes. Stomach cancer is particularly important
because of its relatively high incidence in this region. A
large body of evidence supports a causative role for Heli-
cobacter pylori in chronic gastritis [43]. H. pylori infec-
tion also increases the risk of stomach cancer [44]. A
seroepidemiologic study in different parts of Iran revealed
near 90% prevalence of H. pylori infection in adults older
than 35 years [45]. Also, a recent study in Ardabil, which
is a province in the western part of the Caspian region,
revealed nearly 90% H. pylori infection in the healthy
population older than 40 years [46].
A diet low in fresh fruits and vegetables, high intake of
nitrates/nitrites (e.g., in water and preserved foods), and
low SES are other important risk factors for stomach can-
cer [39]. There was a significant positive correlation
between SIR's of esophageal and stomach cancer which
may be an indication that these two cancer sites in the
region share common risk factors such as smoking, low
socio-economic status, low fruit and vegetable intake, and
gastric atrophy [47-51].
Colorectal Cancer
There was a dispersed pattern for colorectal cancer in both
sexes, with a tendency to relatively high rates in central
wards; this pattern was supported by a strong significant
correlation between SIR's of males and females (0.71).
There was a moderate negative correlation (-0.25)
between SIR's of colorectal and esophageal cancer. In fact,
eastern wards of Golestan province (Turkmen plain)
which were high in esophageal cancer were among the
lowest in colorectal cancer. Colorectal cancer is believed
to be related to low levels of fiber consumption and high
SES [39]. Accordingly, the fact that 55.9% of male and
57.7% of female inhabitants in the three local clusters of
colorectal cancer lived in urban areas whereas only 42.3%
of males and 42.2% of females outside the clusters lived
Spatial pattern, local clusters (wards shaded with "dots" indicate the most likely clusters, and wards shaded with "slashes" indi- cate the secondary clusters), and smoothed RR of esophageal cancer incidence Figure 3
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in urban areas may be related to differences in diet and
SES between urban and rural area.
Liver Cancer
Viral hepatitis is the major cause of liver disease and hepa-
tocellular carcinoma. Up to 80% of liver cancers are
believed to result from this viral infection which is the
most important cause of cancer mortality worldwide after
smoking. Data obtained from the Survey of Health and
Disease in Iran indicted that the rate of hepatitis B virus
(HBV) carriers varied between zero and 3.9% in different
provinces of Iran with an average of 1.7% [52]. Hepatitis
C virus (HCV) is another important risk factor and it has
been shown that approximately 85% of individuals
infected by HCV will develop chronic HCV infection [53].
In Iran, it seems that the prevalence of HCV in the general
population is less than 1%, which is much lower than in
most of the neighboring countries [54]. Currently, there
are no data available about infection rates of HBV and
HCV within the Caspian region.
Pancreas Cancer
Cancer of the pancreas had low prevalence and there was
little evidence of spatial trends. The distribution of pan-
creas rates in the region was similar to a random pattern,
and there was low correlation (0.09) between male and
female rates.
Conclusion
With media attention and an atmosphere of concern
among the general population, it was difficult to dispas-
sionately assess the strength of evidence for the existence
of the hypothesized clusters of gastrointestinal tract cancer
in northern Iran. The difficulty was compounded by the
variety and complexity of available statistical methods for
assessing the spatial variation of disease. Appropriate sta-
tistical methods for evaluation of geographic differences
Spatial pattern, local clusters (wards shaded with "dots" indicate the most likely clusters, and wards shaded with "slashes" indi- cate the secondary clusters), and smoothed RR of stomach cancer Figure 4
Spatial pattern, local clusters (wards shaded with "dots" indicate the most likely clusters, and wards shaded with "slashes" indi-
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should i) provide global indices that summarize the spa-
tial pattern of the disease, ii) smooth the observed map of
disease for potential sampling variation while accounting
for both region contiguity and region heterogeneity, and
iii) search for possible disease clusters in a manner that
adjust for the pre-selection bias and multiple testing
effects. In this paper we used Moran's I and Geary's C as
global autocorrelation indexes, a hierarchical Bayesian
model for smoothing the cancer rates, and spatial scan sta-
tistics for cluster detection.
When a cluster of high incidence cannot be dismissed as a
chance occurrence as is the case with many of the findings
in this paper, we need to ask what may be the underlying
causal mechanism. It is most natural to look first at some
of the known or hypothesized risk factors. We have dem-
onstrated that several cancer sites have significant regional
variation in the Caspian region. An explanation for this
spatial variation, however, requires further study, espe-
cially concerning the possible impact of environmental
factors. Ecologic studies of the kind described here pro-
vide a relatively inexpensive way of examining regional
variation in health in large populations. The effects of
environmental factors can also be addressed by access to
existing data sets. However, these studies involve interpre-
tational problems arising from the aggregation of data
and potential sources of bias such as variation in the size
of the regional populations, migration, and disease
latency [55,56].
With its large population, interesting regional pattern of
GI cancer incidence as demonstrated here, differences in
climate, life style, ethnic mix and variation in recognized
risk factors, the Caspian region warrants further study into
the relationship between environment and GI cancer.
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